bb93c1673e
archive/ — unused reference files (no active code references): - LookupSearchTermCleanedDrugName.csv, condition_directorate_mapping.csv - na_directory_rows.csv (diagnostic output), ta-recommendations.xlsx - snomed_indication_mapping_query.sql (source for embedded SQL) - IMPROVEMENT_RECOMMENDATIONS.md, power query.pq archive/can_delete/ — legacy code and logs safe to remove: - dashboard_gui.py (replaced by Reflex app) - pathways_app_old.py.bak (old backup) - Ralph loop iteration logs (iterations 2-8)
9.5 KiB
9.5 KiB
| 1 | Search_Term | CleanedDrugName | |
|---|---|---|---|
| 2 | 0 | acute coronary syndrome | ABCIXIMAB|CLOPIDOGREL|PRASUGREL|RIVAROXABAN|TICAGRELOR |
| 3 | 1 | acute lymphoblastic leukaemia | BLINATUMOMAB|DASATINIB|INOTUZUMAB|PEGASPARGASE|PONATINIB|TISAGENLECLEUCEL |
| 4 | 2 | acute myeloid leukaemia | AZACITIDINE|DECITABINE|GEMTUZUMAB|GILTERITINIB|GLASDEGIB|LIPOSOMAL|MIDOSTAURIN|ORAL|VENETOCLAX |
| 5 | 3 | acute promyelocytic leukaemia | ARSENIC|GEMTUZUMAB |
| 6 | 4 | allergic asthma | OMALIZUMAB |
| 7 | 5 | allergic rhinitis | SQ |
| 8 | 6 | alzheimer's disease | DONEPEZIL |
| 9 | 7 | amyloidosis | VUTRISIRAN |
| 10 | 8 | anaemia | ERYTHROPOIESIS-STIMULATING|ERYTHROPOIETIN |
| 11 | 9 | anaplastic large cell lymphoma | BRENTUXIMAB |
| 12 | 10 | ankylosing spondylitis | ADALIMUMAB|GOLIMUMAB|SECUKINUMAB|UPADACITINIB |
| 13 | 11 | apixaban | ANDEXANET |
| 14 | 12 | aplastic anaemia | ELTROMBOPAG |
| 15 | 13 | arthritis | ETANERCEPT |
| 16 | 14 | asthma | BENRALIZUMAB|DUPILUMAB|INHALED|MEPOLIZUMAB|OMALIZUMAB|RESLIZUMAB |
| 17 | 15 | atopic dermatitis | ABROCITINIB|ALCLOMETASONE|BARICITINIB|CRISABOROLE|DUPILUMAB|PIMECROLIMUS |
| 18 | 16 | atrial fibrillation | APIXABAN|DABIGATRAN|DRONEDARONE|EDOXABAN|RIVAROXABAN|VERNAKALANT |
| 19 | 17 | attention deficit hyperactivity disorder | ATOMOXETINE |
| 20 | 18 | attention-deficit hyperactivity disorder | METHYLPHENIDATE |
| 21 | 19 | axial spondyloarthritis | ADALIMUMAB|GOLIMUMAB|IXEKIZUMAB|SECUKINUMAB|UPADACITINIB |
| 22 | 20 | basal cell carcinoma | VISMODEGIB |
| 23 | 21 | bipolar disorder | LOXAPINE|OLANZAPINE |
| 24 | 22 | bladder | MIRABEGRON |
| 25 | 23 | brca | OLAPARIB |
| 26 | 24 | breast cancer | ABEMACICLIB|ALPELISIB|ANASTROZOLE|ATEZOLIZUMAB|BEVACIZUMAB|CAPECITABINE|DENOSUMAB|DOCETAXEL|ERIBULIN|EVEROLIMUS|FULVESTRANT|GEMCITABINE|INTRABEAM|LAPATINIB|NERATINIB|OLAPARIB|PACLITAXEL|PALBOCICLI|PALBOCICLIB|PEMBROLIZUMAB|PERTUZUMAB|RIBOCICLIB|SACITUZUMAB|TRASTUZUMAB|TUCATINIB|VINORELBINE |
| 27 | 25 | cardiomyopathy | TAFAMIDIS |
| 28 | 26 | cardiovascular disease | ATORVASTATIN |
| 29 | 27 | cervical cancer | TOPOTECAN |
| 30 | 28 | cholangiocarcinoma | PEMIGATINIB |
| 31 | 29 | choroidal neovascularisation | AFLIBERCEPT|RANIBIZUMAB |
| 32 | 30 | chronic kidney disease | DAPAGLIFLOZIN|IMLIFIDASE|ROXADUSTAT |
| 33 | 31 | chronic liver disease | AVATROMBOPAG|LUSUTROMBOPAG |
| 34 | 32 | chronic lymphocytic leukaemia | ACALABRUTINIB|BENDAMUSTINE|DUVELISIB|IBRUTINIB|IDELALISIB|OBINUTUZUMAB|OFATUMUMAB|RITUXIMAB|VENETOCLAX |
| 35 | 33 | chronic myeloid leukaemia | ASCIMINIB|BOSUTINIB|STANDARD-DOSE|DASATINIB|DASITINIB|NILOTINIB|PONATINIB |
| 36 | 34 | chronic obstructive pulmonary disease | ROFLUMILAST |
| 37 | 35 | colon cancer | CAPECITABINE |
| 38 | 36 | colorectal cancer | BEVACIZUMAB|CAPECITABINE|IRINOTECAN |
| 39 | 37 | constipation | LUBIPROSTONE|METHYLNALTREXONE|NALDEMEDINE|NALOXEGOL|PRUCALOPRIDE |
| 40 | 38 | covid-19 | NIRMATRELVIR |
| 41 | 39 | crohn's disease | INFLIXIMAB|VEDOLIZUMAB |
| 42 | 40 | cutaneous t-cell lymphoma | BRENTUXIMAB|CHLORMETHINE |
| 43 | 41 | cystic fibrosis | COLISTIMETHATE|LUMACAFTOR|MANNITOL |
| 44 | 42 | cytomegalovirus | LETERMOVIR|MARIBAVIR |
| 45 | 43 | deep vein thrombosis | APIXABAN|DABIGATRAN|EDOXABAN|RIVAROXABAN |
| 46 | 44 | depression | ESKETAMINE |
| 47 | 45 | diabetes | ERTUGLIFLOZIN|INHALED|AFLIBERCEPT|BROLUCIZUMAB|DEXAMETHASONE|FARICIMAB|FLUOCINOLONE|RANIBIZUMAB |
| 48 | 46 | diabetic retinopathy | RANIBUZIMAB |
| 49 | 47 | diffuse large b-cell lymphoma | AXICABTAGENE|POLATUZUMAB|TISAGENLECLEUCEL |
| 50 | 48 | dravet syndrome | CANNABIDIOL|FENFLURAMINE |
| 51 | 49 | drug misuse | BUPRENORPHINE|NALTREXONE |
| 52 | 50 | dry eye | CICLOSPORIN |
| 53 | 51 | dyspepsia | LANSOPRAZOLE |
| 54 | 52 | endometrial cancer | DOSTARLIMAB |
| 55 | 53 | epilepsy | CENOBAMATE|GABAPENTIN|RETIGABINE |
| 56 | 54 | fallopian tube | BEVACIZUMAB|NIRAPARIB|OLAPARIB|RUCAPARIB |
| 57 | 55 | follicular lymphoma | DUVELISIB|IDELALISIB|LENALIDOMIDE|OBINUTUZUMAB|RITUXIMAB|TISAGENLECLEUCEL |
| 58 | 56 | gastric cancer | CAPECITABINE|RAMUCIRUMAB|TRASTUZUMAB|TRIFLURIDINE |
| 59 | 57 | gastro-oesophageal junction | NIVOLUMAB|PEMBROLIZUMAB |
| 60 | 58 | giant cell arteritis | TOCILIZUMAB |
| 61 | 59 | glioma | CARMUSTINE |
| 62 | 60 | gout | CANAKINUMAB|FEBUXOSTAT|LESINURAD |
| 63 | 61 | graft versus host disease | RUXOLITINIB |
| 64 | 62 | granulomatosis with polyangiitis | AVACOPAN|MEPOLIZUMAB |
| 65 | 63 | growth hormone deficiency | SOMATROPIN |
| 66 | 64 | hand eczema | ALITRETINOIN |
| 67 | 65 | heart failure | DAPAGLIFLOZIN|EMPAGLIFLOZIN|IVABRADINE|SACUBITRIL|VERICIGUAT |
| 68 | 66 | hepatitis b | ADEFOVIR |
| 69 | 67 | hepatitis c | BOCEPREVIR|DACLATASVIR|ELBASVIR|GLECAPREVIR|INTERFERON|LEDIPASVIR|OMBITASVIR|PEGINTERFERON|PEGYLATED|SIMEPREVIR|SOFOSBUVIR|TELAPREVIR |
| 70 | 68 | hepatocellular carcinoma | ATEZOLIZUMAB|CABOZANTINIB|LENVATINIB|RAMUCIRUMAB|REGORAFENIB|SELECTIVE|SORAFENIB |
| 71 | 69 | hiv | CABOTEGRAVIR |
| 72 | 70 | hodgkin lymphoma | BRENTUXIMAB|NIVOLUMAB|PEMBROLIZUMAB |
| 73 | 71 | hormone receptor | ABEMACICLIB |
| 74 | 72 | hypercholesterolaemia | EZETIMIBE |
| 75 | 73 | hyperparathyroidism | CINACALCET|ETELCALCETIDE |
| 76 | 74 | immune thrombocytopenia | AVATROMBOPAG|FOSTAMATINIB |
| 77 | 75 | influenza | AMANTADINE|ZANAMIVIR|BALOXAVIR |
| 78 | 76 | insomnia | ZALEPLON |
| 79 | 77 | irritable bowel syndrome | ELUXADOLINE |
| 80 | 78 | ischaemic stroke | ALTEPLASE |
| 81 | 79 | juvenile idiopathic arthritis | ABATECEPT|CANAKINUMAB|TOCILIZUMAB|TOFACITINIB |
| 82 | 80 | kidney transplant | BASILIXIMAB |
| 83 | 81 | leukaemia | FLUDARABINE|IMATINIB |
| 84 | 82 | lung cancer | ATEZOLIZUMAB|DURVALUMAB|GEFITINIB|ORAL|NINTEDANIB |
| 85 | 83 | lymphoma | BENDAMUSTINE|CRIZOTINIB|PIXANTRONE|RITUXIMAB |
| 86 | 84 | macular degeneration | AFLIBERCEPT|BROLUCIZUMAB|FARICIMAB|RANIBIZUMAB |
| 87 | 85 | macular oedema | AFLIBERCEPT|RANIBIZUMAB |
| 88 | 86 | major depressive episodes | AGOMELATINE|VORTIOXETINE |
| 89 | 87 | malignant melanoma | VEMURAFENIB |
| 90 | 88 | malignant pleural mesothelioma | NIVOLUMAB|PEMETREXED |
| 91 | 89 | manic episode | ARIPIPRAZOLE |
| 92 | 90 | mantle cell lymphoma | AUTOLOGOUS|BORTEZOMIB|IBRUTINIB|LENALIDOMIDE|TEMSIROLIMUS |
| 93 | 91 | melanoma | COBIMETINIB|DABRAFENIB|ENCORAFENIB|IPILIMUMAB|NIVOLUMAB|PEMBROLIZUMAB|TALIMOGENE|TRAMETINIB |
| 94 | 92 | merkel cell carcinoma | AVELUMAB |
| 95 | 93 | migraine | BOTULINUM|EPTINEZUMAB|ERENUMAB|FREMANEZUMAB|GALCANEZUMAB |
| 96 | 94 | motor neurone disease | RILUZOLE |
| 97 | 95 | multiple myeloma | BORTEZOMIB|THALIDOMIDE|CARFILZOMIB|DARATUMUMAB|DENOSUMAB|ELOTUZUMAB|ISATUXIMAB|IXAZOMIB|LENALIDOMIDE|PANOBINOSTAT|POMALIDOMIDE|SELINEXOR|TECLISTAMAB |
| 98 | 96 | multiple sclerosis | ALEMTUZUMAB|BETA|CLADRIBINE|DACLIZUMAB|DIMETHYL|DIROXIMEL|FINGOLIMOD|INTERFERON|NATALIZUMAB|OCRELIZUMAB|OZANIMOD|PEGINTERFERON|PONESIMOD|SIPONIMOD|TERIFLUNOMIDE |
| 99 | 97 | myelodysplastic | LENALIDOMIDE|LUSPATERCEPT |
| 100 | 98 | myelofibrosis | FEDRATINIB|RUXOLITINIB |
| 101 | 99 | myocardial infarction | ALTEPLASE|BIVALIRUDIN|TICAGRELOR |
| 102 | 100 | myotonia | MEXILETINE |
| 103 | 101 | narcolepsy | SOLRIAMFETOL |
| 104 | 102 | neuroendocrine tumour | EVEROLIMUS|LUTETIUM |
| 105 | 103 | non-small cell lung cancer | ATEZOLIZMAB|DOCETAXEL|ERLOTINIB|PEMETREXED |
| 106 | 104 | non-small-cell lung cancer | AFATINIB|ALECTINIB|AMIVANTAMAB|ATEZOLIZUMAB|BEVACIZUMAB|BRIGATINIB|CEMIPLIMAB|CERITINIB|CRIZOTINIB|DABRAFENIB|DACOMITINIB|DURVALUMAB|ENTRECTINIB|ERLOTINIB|GEFITINIB|LORLATINIB|MOBOCERTINIB|NECITUMUMAB|NIVOLUMAB|OSIMERTINIB|PACLITAXEL|PEMBROLIZUMAB|PEMETREXED|PRALSETINIB|RAMUCIRUMAB|SELPERCATINIB|SOTORASIB|TEPOTINIB |
| 107 | 105 | obesity | LIRAGLUTIDE|NALTREXONE|ORLISTAT|SEMAGLUTIDE|SIBUTRAMINE |
| 108 | 106 | oesophageal cancer | NIVOLUMAB |
| 109 | 107 | osteoarthritis | CELECOXIB |
| 110 | 108 | osteoporosis | ALENDRONATE|DENOSUMAB|ORAL|ROMOSOZUMAB |
| 111 | 109 | osteosarcoma | MIFAMURTIDE |
| 112 | 110 | ovarian cancer | BEVACIZUMAB|PACLITAXEL|PEGYLATED|TOPOTECAN|TRABECTEDIN |
| 113 | 111 | overweight | RIMONABANT |
| 114 | 112 | pancreatic cancer | GEMCITABINE|OLAPARIB|PACLITAXEL|PEGYLATED |
| 115 | 113 | paroxysmal nocturnal haemoglobinuria | PEGCETACOPLAN|RAVULIZUMAB |
| 116 | 114 | peripheral arterial disease | NAFTIDROFYRYL |
| 117 | 115 | plaque psoriasis | ADALIMUMAB|APREMILAST|BIMEKIZUMAB|BRODALUMAB|CERTOLIZUMAB|GUSELKUMAB|INFLIXIMAB|IXEKIZUMAB|RISANKIZUMAB|SECUKINUMAB|TILDRAKIZUAMB|USTEKINUMAB |
| 118 | 116 | polycystic kidney disease | TOLVAPTAN |
| 119 | 117 | polycythaemia vera | RUXOLITINIB |
| 120 | 118 | pregnancy | ROUTINE |
| 121 | 119 | primary biliary cholangitis | OBETICHOLIC |
| 122 | 120 | primary hypercholesterolaemia | ALIROCUMAB|EVOLOCUMAB |
| 123 | 121 | prostate cancer | ABIRATERONE|APALUTAMIDE|CABAZITAXEL|DAROLUTAMIDE|DEGARELIX|DENOSUMAB|DOCETAXEL|ENZALUTAMIDE|OLAPARIB|PADELIPORFIN|RADIUM-|RADIUM|SIPULEUCEL-T |
| 124 | 122 | psoriasis | EFALUZIMAB |
| 125 | 123 | psoriatic arthritis | ABATACEPT|ADALIMUMAB|APREMILAST|CERTOLIZUMAB|ETANERCEPT|GOLIMUMAB|GUSELKUMAB|IXEKIZUMAB|RISANKIZUMAB|TOFACITINIB|UPADACITINIB|USTEKINUMAB |
| 126 | 124 | pulmonary embolism | APIXABAN|DABIGATRAN|EDOXABAN|RIVAROXABAN |
| 127 | 125 | pulmonary fibrosis | NINTEDANIB|PIRFENIDONE |
| 128 | 126 | relapsing multiple sclerosis | OFATUMUMAB |
| 129 | 127 | renal cell carcinoma | AVELUMAB|AXITINIB|BEVACIZUMAB|CABOZANTINIB|EVEROLIMUS|LENVATINIB|NIVOLUMAB|PAZOPANIB|PEMBROLIZUMAB|SUNITINIB|TIVOZANIB |
| 130 | 128 | renal transplantation | BASILIXIMAB|INDUCTION |
| 131 | 129 | retinal vein occlusion | AFLIBERCEPT|DEXAMETHASONE|RANIBIZUMAB |
| 132 | 130 | rheumatoid arthritis | ABATACEPT|ADALIMUMAB|ANAKINRA|BARICITINIB|CELECOXIB|CERTOLIZUMAB|ETANERCEPT|FILGOTINIB|GOLIMUMAB|RITUXIMAB|SARILUMAB|TOCILIZUMAB|TOFACITINIB|UPADACITINIB |
| 133 | 131 | rivaroxaban | ANDEXANET |
| 134 | 132 | schizophrenia | AMISULPRIDE|ARIPIPRAZOLE|LOXAPINE |
| 135 | 133 | seizures | CANNABIDIOL |
| 136 | 134 | sepsis | DROTRECOGIN |
| 137 | 135 | severe persistent allergic asthma | OMALIZUMAB |
| 138 | 136 | short bowel syndrome | TEDUGLUTIDE |
| 139 | 137 | sickle cell disease | CRIZANLIZUMAB |
| 140 | 138 | sleep apnoea | PITOLISANT|SOLRIAMFETOL |
| 141 | 139 | smoking cessation | NICOTINE|VARENICLINE |
| 142 | 140 | soft tissue sarcoma | INTRAVENOUS|NBTXR-|OLARATUMAB |
| 143 | 141 | spinal muscular atrophy | NUSINERSEN|RISDIPLAM |
| 144 | 142 | squamous cell | CETUXIMAB |
| 145 | 143 | squamous cell carcinoma | CEMIPLIMAB|NIVOLUMAB|PEMBROLIZUMAB |
| 146 | 144 | stem cell transplant | MELPHALAN|TREOSULFAN |
| 147 | 145 | stroke | APIXABAN|DABIGATRAN|EDOXABAN|RIVAROXABAN |
| 148 | 146 | systemic lupus erythematosus | ANIFROLUMAB|ETANERCEPT |
| 149 | 147 | systemic mastocytosis | MIDOSTAURIN |
| 150 | 148 | thrombocytopenic purpura | ELTROMBOPAG|ROMIPLOSTIM |
| 151 | 149 | thrombotic thrombocytopenic purpura | CAPLACIZUMAB |
| 152 | 150 | thyroid cancer | CABOZANTINIB|LENVATINIB|SELPERCATINIB|VANDETANIB |
| 153 | 151 | tophaceous gout | PEGLOTICASE |
| 154 | 152 | transitional cell carcinoma | VINFLUNINE |
| 155 | 153 | tuberous sclerosis | CANNABIDIOL |
| 156 | 154 | type 1 diabetes | CONTINUOUS|DAPAGLIFLOZIN|INSULIN|SOTAGLIFLOZIN |
| 157 | 155 | type 2 diabetes | CANAGLIFLOZIN|CONTINUOUS|DAPAGLIFLOZIN|EMPAGLIFLOZIN|ERTUGLIFLOZIN|EXENATIDE|FINERENONE|INSULIN|LIRAGLUTIDE|PIOGLITAZONE|ROSIGLITAZONE |
| 158 | 156 | ulcerative colitis | ADALIMUMAB|INFLIXIMAB|FILGOTINIB|OZANIMOD|TOFACITINIB|UPADACITINIB|USTEKINUMAB|VEDOLIZUMAB |
| 159 | 157 | urothelial carcinoma | ATEZOLIZUMAB|PEMBROLIZUMAB |
| 160 | 158 | urticaria | OMALIZUMAB |
| 161 | 159 | uterine fibroids | RELUGOLIX |
| 162 | 160 | uveitis | ADALIMUMAB|FLUOCINOLONE |
| 163 | 161 | vascular disease | MODIFIED-RELEASE|CLOPIDOGREL |
| 164 | 162 | vasculitis | RITUXIMAB |
| 165 | 163 | venous thromboembolism | APIXABAN|DABIGATRAN|RIVAROXABAN |